UpdatesGeneral Updates
Nath Bio-Genes delivered strong Q1FY27 results: Revenue grew 15% to ₹322.8 Cr, EBITDA rose 17% to ₹35.1 Cr, and PAT increased 12% to ₹32.7 Cr.
Nath Bio-Genes (India) LimitedNATHBIOGEN · Filed with the exchange
Operational highlights include Maize volume up 44% (value 59%) and Paddy volume up 19% (value 34%).
No comments yet. Be the first.